Format

Send to

Choose Destination
J Pediatr. 2010 Mar;156(3):501-3. doi: 10.1016/j.jpeds.2009.10.048. Epub 2010 Jan 13.

Clindamycin-resistant group B Streptococcus and failure of intrapartum prophylaxis to prevent early-onset disease.

Author information

1
Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, USA. anne.blaschke@hsc.utah.edu

Abstract

Guidelines recommend intrapartum antibiotic prophylaxis (IAP) for parturient women who have a screen positive for group B Streptococcus (GBS). Clindamycin should be used for IAP only if the maternal GBS isolate is susceptible. We report a case of clindamycin-resistant GBS disease in a newborn infant whose mother received clindamycin IAP, and we review clindamycin susceptibility testing.

PMID:
20056242
PMCID:
PMC3153078
DOI:
10.1016/j.jpeds.2009.10.048
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center